CNL Healthcare Properties, Inc.
OTC:CHTH
4.41 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 341.48 | 322.661 | 295.422 | 307.141 | 321.891 | 311.594 | 398.416 | 377.055 | 300.525 | 181.084 | 52.605 | 8.528 |
| Cost of Revenue
| 318.723 | 226.845 | 197.562 | 193.427 | 188.535 | 181.299 | 243.612 | 228.607 | 182.339 | 110.972 | 27.196 | 2.179 |
| Gross Profit
| 22.757 | 95.816 | 97.86 | 113.714 | 133.356 | 130.295 | 154.804 | 148.448 | 118.186 | 70.112 | 25.409 | 6.349 |
| Gross Profit Ratio
| 0.067 | 0.297 | 0.331 | 0.37 | 0.414 | 0.418 | 0.389 | 0.394 | 0.393 | 0.387 | 0.483 | 0.744 |
| Reseach & Development Expenses
| -0 | 0 | -0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 38.395 | 38.986 | 37.83 | 41.236 | 44.296 | 45.303 | 11.924 | 11.938 | 10.088 | 6.877 | 5.618 | 2.563 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 1.086 | 0.909 | 0 | 0 | 0 | 0 |
| SG&A
| 38.395 | 38.986 | 37.83 | 41.236 | 44.296 | 45.303 | 13.01 | 12.847 | 10.088 | 6.877 | 5.618 | 2.563 |
| Other Expenses
| -5.901 | 54.242 | 50.417 | 51.817 | 49.823 | 54.13 | 107.944 | 122.985 | 105.945 | 63.112 | 16.765 | 0 |
| Operating Expenses
| 5.901 | 93.228 | 88.247 | 93.053 | 94.119 | 99.433 | 120.954 | 135.832 | 116.033 | 69.989 | 22.383 | 11.709 |
| Operating Income
| 16.856 | 8.87 | 10.804 | 21.735 | 37.791 | 23.989 | 31.055 | 11.147 | -24.308 | -23.178 | -13.99 | 1.685 |
| Operating Income Ratio
| 0.049 | 0.027 | 0.037 | 0.071 | 0.117 | 0.077 | 0.078 | 0.03 | -0.081 | -0.128 | -0.266 | 0.198 |
| Total Other Income Expenses Net
| -41.96 | -8.742 | -29.486 | -17.58 | -37.143 | -6.384 | 0.356 | 14.204 | -27.057 | -21.89 | -10.383 | -12.422 |
| Income Before Tax
| -25.104 | 0.128 | -18.682 | 4.155 | 0.648 | -17.111 | -34.675 | -31.433 | -67.715 | -52.15 | -18.082 | -10.737 |
| Income Before Tax Ratio
| -0.074 | 0 | -0.063 | 0.014 | 0.002 | -0.055 | -0.087 | -0.083 | -0.225 | -0.288 | -0.344 | -1.259 |
| Income Tax Expense
| 0.56 | 0.54 | 4.174 | 1.098 | 2.189 | 3.631 | -8.363 | 0.351 | 0.378 | 0.361 | 0.018 | 0.017 |
| Net Income
| -25.698 | -0.412 | -22.856 | 3.057 | -1.541 | -25.072 | -25.962 | -31.667 | -68.055 | -52.511 | -18.1 | -10.72 |
| Net Income Ratio
| -0.075 | -0.001 | -0.077 | 0.01 | -0.005 | -0.08 | -0.065 | -0.084 | -0.226 | -0.29 | -0.344 | -1.257 |
| EPS
| -0.15 | -0.002 | -0.13 | 0.018 | -0.009 | -0.14 | -0.15 | -0.18 | -0.44 | -0.61 | -0.42 | -0.81 |
| EPS Diluted
| -0.15 | -0.002 | -0.13 | 0.018 | -0.009 | -0.14 | -0.15 | -0.18 | -0.44 | -0.61 | -0.42 | -0.81 |
| EBITDA
| 68.09 | 61.493 | 61.221 | 79.183 | 89.444 | 85.816 | 140.129 | 136.676 | 108.575 | 62.297 | 22.08 | 3.786 |
| EBITDA Ratio
| 0.199 | 0.191 | 0.207 | 0.258 | 0.278 | 0.275 | 0.352 | 0.362 | 0.361 | 0.344 | 0.42 | 0.444 |